BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
SIRT1
,
Fatty acid metabolic process
,
Arthritis
,
Retina
,
Laryngoscope
,
Fluoxetine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
carbapenems
NextBio Summary
General Info
Curated Studies
Most Correlated Studies
Drug Matrix In Vivo Toxicogenomic Study - Rat Spleen [Codelink]
Neural 3D tissue constructs from H1 ESC-derived precursor cells treated with neurotoxic chemicals
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Recent updates of carbapenem antibiotics.
Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-d…
Carbapenem-resistant Enterobacteriaceae (CRE): a menace to the public and the mechanisms of antimicr…
Carbapenem-Resistant Enterobacteriaceae.
Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Deescalating Carbapenems in Hospital Setting
Carbapenems De-escalation as Antimicrobial Stewardship
Comparison of Bloodstream Infections With Carbapenem Hetero-resistant vs Carbapenem Resistant Klebsi…
Emergence of Resistance in Intestinal Microflora During Carbapenem Treatments
BetaLACTA® Test for Early De-escalation of Empirical Carbapenems in Pulmonary, Urinary and Bloodstre…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ